CellPro Ceprate SC Injunction And $7 Mil. Fine Upheld By U.S. Appeals Court
This article was originally published in The Gray Sheet
Executive Summary
CellPro plans to establish a European facility to provide the antibody used in its Ceprate SC stem cell selection technology following an Aug. 11 decision by the U.S. Court of Appeals for the Federal Circuit to uphold a partial injunction and $7 mil. fine handed down as part of a patent infringement ruling entered against CellPro in March 1997.